lacrimal functions may result in poor surgical outcomes, especially after penetrating keratoplasty or limbal stem cell transplantation. Traditionally, the eyelids and lacrimal gland were excluded from the definition of the ocular surface. It is evident that visual function and epithelial health would not be feasible without these structures. The eyelids are essential for ocular surface protection and tear film maintenance. Untreated eyelid deformities, lid malpositions, or eyelash misalignments can precipitate detrimental consequences to the integrity and function of the ocular surface epithelia. Thus, a functional ocular surface requires structurally and functionally intact eyelids and lacrimal gland.
Ocular surface reconstitution
In severe ocular surface disorders, the management strategies entail symptomatic relief, reconstitution of the anatomic and physiologic ocular surface, and treatment and prevention of recurrence of the causative condition. Here we will discuss strategies to restore the conjunctival epithelium, corneal epithelium, and lacrimal function. Figure 1 illustrates the management strategies. Injury or inflammation causes severe ocular surface disorder with conjunctival scarring, limbal stem cell deficiency, corneal opacity with neovascularization, lacrimal dysfunction, disorganized lashes, and lid malposition (a). Mainstay treatment options include antibiotics, anti-inflammatory agents, lubrication, and amniotic membrane transplantation, as well as removal of lashes and correction of lid changes (b). As progress is made in science and tissue bioengineering, tissue replacement and regeneration may be feasible to restore the ocular surface and vision (c).
Conjunctival tissue reconstitution 2.1.1 Suppression of cicatricial changes
Commonly, ocular surface diseases limited to the conjunctiva progress to excessive cicatricial changes and loss of normal epithelial anatomy. Cicatricial changes to the conjunctival epithelium generally result from poorly controlled fibroblastic activities, e.g. tissue injuries or persistent inflammation. In addition to disrupting the tear film, cicatricialization of the conjunctiva has important implications in glaucoma surgeries, where availablility of healthy conjunctiva is essential for good surgical outcomes. A widely adopted therapeutic strategy is pharmacologic suppression of the inflammatory cascade and the fibroblast activation pathway using corticosteroids and antimetabolites. Recently, research efforts have been directed toward transforming growth factor beta (TGF-) and its involvement in fibroblast proliferation. TGF-is a multifunctional cytokine, which plays an important role in tissue repair and regeneration. After injury, TGF-triggers a complex cascade involving monocyte and leukocyte chemotaxis, induction of angiogenesis, control of production of cytokines and inflammatory mediators, deposition of extracellular matrix materials, and prevention of their enzymatic degradation (Border & Ruoslahti, 1992; Massagué et al., 1992) . Excessive TGF-activity has been associated with exuberant fibrotic changes in the eye and other organs. In a murine model, TGF-was associated with formation of granulation tissue (Roberts et al., 1986 ) and increased inflammatory cell activity, as well as with exuberant extracellular collagen type-III deposition (Siriwardena et al., 1999) . Using immunohistochemistry, Razzaque et al (2003) found increased accumulations of type-I and type III collagens and heat shock protein 47, a collagen-binding protein in fibrotic conjunctiva of patients with ocular cicatricial pemphigoid compared to normal subjects. Up-regulation of these proteins was also detected when ex-vivo conjunctival fibroblasts were treated with TGF-. Elevated levels of bone morphogenetic protein-6 and activin A, both part of the TGF-superfamily, have been reported in scar tissue after glaucoma incisional surgeries, and their mRNA expression was immunolocalized to epithelial cells, vascular endothelia, stromal fibroblasts, and macrophage-like cells using real-time polymerase chain reaction (Andreev et al., 2006) . It is suggested that these multifunctional growth factors participate in tissue wound healing, and altered expression of these factors may play a role in conjunctival scarring. It is, therefore, hypothesized that modulation of TGF-activity may help control the formation of scar tissue. Indeed, this has been demonstrated in animal models and clinical trials. CAT-152 is a human monoclonal antibody capable of neutralizing the growth factor TGF-2. In in vitro and in vivo models, CAT-152 was shown to inhibit conjunctival scarring Thompson et al., 1999) . In a rabbit model, SB-431542, a potent and selective inhibitor of the TGF-1 activin receptor-like kinase, decreases subconjunctival deposition of collagen in rabbits undergoing glaucoma filtration surgery (Xiao et al., 2009) . It is thought that SB-431542 inhibits phosphorylation of Smad2 stimulated by TGF-, abrogating fibroblast transdifferentiation and type-I collagen synthesis. A prospective randomized placebo controlled clinical study of patients undergoing trabeculectomy showed that subconjunctival injection of CAT-152 appears to be safe in human undergoing trabeculectomy (Cordeiro 2003; Siriwardena et al., 2002) . Successful and safe suppression of TGF-superfamily activities may modulate fibroblast proliferation and cicatricial changes to the conjunctiva. An alternative approach is stimulation of tissue regrowth and reduction of the conjunctival wound contraction mediated by modified contractile fibroblasts using biocompatible porous matrices Majno et al 1971) . In a guinea pig skin model, highly porous, cross-linked collagen-glycosaminoglycan copolymer matrix had been reported to induce partial morphogenesis of skin when seeded with dermal and epidermal cells. After grafting on a full-thickness skin wound model (Yannas et al., 1982 (Yannas et al., , 1989 , the seeded matrix regenerated mature epidermis and near physiologic dermis, which was distinct from scar tissue and able to prevent wound contraction, compared to non-seeded matrix. For ophthalmic applications, porous collagen-glycosaminoglycan copolymer matrix was shown to decrease wound contraction in a full-thickness defect in a rabbit conjunctival model (Hsu et al., 2000) . In animal glaucoma filtration surgery model, implantation of biodegradable porous collagen matrix in the subconjunctival space was associated with less initial scar formation and maintenance of long-term intraocular pressure control (Chen et al., 2006) . In this study, Masson trichrome and -smooth muscle actin immunocytochemistry established reduction of myofibroblast population in the eye having bioactive matrix implant compared to control. The authors concluded that the collagen matrix may simulate a more physiological structure for tissue regrowth (Chen et al., 2006; Hsu et al., 2000) . Scleral buckle composed of biodegradable collagen-glycosaminoglycan copolymer had been reported to be safe and effective in a rabbit model (Wu et al., 2008) . Similar results have been demonstrated with modified porous poly(lactide-co-glycolide) scaffold as well (Lee et al., 2003) . These findings provide insight into cellular behaviors and assist in the understanding of conjunctival tissue bioengineering.
Conjunctival tissue substitutes

Autologous mucosal transplantation
Other therapeutic options for conjunctival tissue reconstitution include autologous tissue grafts and bioengineered conjunctival substitutes. Similar to any epithelia, the conjunctival epithelium is in a dynamic self-renewal equilibrium. Epithelial cells with high mitotic www.intechopen.com capacity are distributed predominantly in the bulbar and forniceal conjunctiva in humans (Pellegrini et al., 1999; Tsubota et al., 2002) . In autologous conjunctival autografts, e.g. for pterygium excision, the conjunctival autograft typically successfully replenishes the donor bed. However, severe tissue deficiency necessitates transplantation of other mucosal tissues. Other mucosal tissues having structure analogous to the conjunctiva, i.e. nonkeratinized stratified squamous epithelium with goblet cells, include nasal, esophageal, vaginal, and tracheal mucosa. Gibson and colleagues (1986) demonstrated the feasibility of transplanting oral epithelium onto the ocular surface in a rabbit model. In a case report, oral mucosa was used in combination with a modified Gunderson conjunctival flap to treat ocular surface burn injury (Cheng & Chang, 2006) . In a series of patients with severe bilateral mucus deficiency syndrome after severe lye, acid, or heat burns, radiation, or systemic mucosal disease, autologous nasal mucosal grafts from the nasal conchae were transplanted to cover the ocular surface (Naumann et al., 1986) . Symptomatic and visual improvements were reported. Long-term follow-up, using impression cytology and hematoxylin and eosin and periodic acid-Schiff staining of biopsied tissue, demonstrated that functional goblet cells persisted in autologous nasal mucosa for up to 10 years after transplantation (Wenkel et al., 2000) . Another study also reported similarly promising outcomes for patients with cicatricial ocular surface secondary to lye injury (Kim et al., 2010) .
Cultivated bioengineered tissues
Currently, a variety of substrates are readily available for cultivation of conjunctival tissue, e.g. murine-derived 3T3 fibroblast feeder layer, human amniotic feeder layer, and serumfree media. Irradiated 3T3 murine feeder cells are widely utilized in a number of cell culture systems because these immortalized 3T3 cells secrete growth factors to support cellular proliferation (Todaro & Green, 1963) . Although the murine-derived feeder layers provide satisfactory support for tissue growth and maintenance, the tissue is unsuitable for human use because of several considerations. The xenoantigenic nonhuman sialic acid Neu5Gc produced by the human embryonic stem cells using this culture system may trigger cell killing in vivo if exposed to human serum containing circulating antibodies specific for Neu5Gc (Martin et al., 2005; Rheinwald 1980 ). Other concerns include transmission of murine diseases or contamination with virus or prion agents (Boneva et al., 2001; Ramarli et al., 1995) . Consequently, alternatives are being explored. The human amniotic feeder layer, derived from human placentas, has been found to promote clonal growth of human limbal epithelial progenitors Tanioka et al., 2006) ). Such bioengineered tissues would be suitable candidates for replacement of native conjunctival tissue as the human amniotic membrane is a stable and elastic substratum that can be integrated into the ocular surface. The anti-inflammatory properties of human amniotic membrane would be especially advantageous in the case of inflammatory cicatricial changes, as any trauma to the recipient bed would reactivate or incite the inflammatory cascade that may inflict further injury to both the host and the graft. Other substrates include ultrathin poly( -caprolactone) membrane, silicone, and others (Ang et al., 2006; Yoon et al., 2007) . To minimize the biohazard of using xenobiotic materials, serum-free media are being investigated as well. One study demonstrated good epithelization following transplantation of serum-free autologous cultivated conjunctival epithelium on human amniotic membrane in pterygium excision (Ang et al., 2005) . Tissue cultivation will be discussed in detail below.
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Corneal epithelium reconstitution
In humans, the known organs that demonstrate immunologic privilege are the eyes, brain, testicles, placenta, and fetus. The anterior chamber immunologic privilege and avascularity of the cornea significantly contribute to the high success rate of corneal allografts, e.g. penetrating keratoplasty, which can be performed without HLA-typing (Nguyen et al., 2007 (Nguyen et al., , 2008 (Nguyen et al., , 2010 . However, the risks of allogeneic graft rejection increase significantly in patients with severe ocular surface disorders or limbal stem cell deficiency. In severe cases, management of corneal blindness involves treatment of the ocular surface disorder, restoration of limbal stem cells, development of corneal tissue equivalents, or use of a keratoprosthesis.
Human amniotic membrane transplantation
Now widely employed in burn management and ophthalmology, the human amniotic membrane found its first applications as surgical dressing and tissue graft in dermal burns and as a strategy to impede tissue adhesion in mucosal injuries (Davis, 1910; Stern, 1913) . Subsequently, its utility was expanded to reconstruction of the oral cavity, bladder, and vagina, as well as tympanoplasty and arthroplasty. De Rotth (1940) first reported the suitability of amniotic membrane in ocular surface reconstruction where he applied the amniochorion to repair symblepharon. A suboptimal surgical outcome was observed because the chorion component can incite inflammation and scarring. The amniotic membrane enjoyed limited use until the 1990s when its properties were better understood and its ophthalmic applications became widely adopted. In humans, the amniotic membrane, which lines the inner surface of the placenta, is composed of a basement membrane and a subjacent stromal matrix devoid of vascular and lymphatic vessels, as well as nerve fibers. It has many unique features, including suppression of inflammation and promotion of tissue healing. In this rat model of Staphylococcus aureus keratitis, histopathologic examination revealed the least corneal haze and neovascularization in the cefazolin/amniotic membrane combination group, compared to the normal saline and amniotic membrane, and cefazolin without amniotic membrane transplantation groups. Complete ocular surface coverage using amniotic membrane was performed in patients with severe acute chemical and thermal burns to protect and promote conjunctival regeneration and to prevent complications of burns, such as symblepharon formation and corneal melt (Joseph et al., 1991) . However, Joseph and colleagues did not observe a positive association between amniotic membrane transplantation and overall success rate of ocular surface restoration or preservation of ocular integrity in patients with severe acute burns, whether used alone or in conjunction with other surgical procedures. Using laser scanning in vivo confocal microscopy, Nubile et al (2001) discovered two different mechanisms of adhesion: when the amniotic membrane behaved as a patch, instead of as a graft, the epithelial cells migrated under the membrane, culminating in membrane disintegration; when the amniotic membrane acted as a graft, it became the basement membrane matrix, integrating with the superficial corneal stroma and allowing epithelial cell migration and proliferation (Nubile et al., 2001; Resch et al., 2006) . This behavior potentially explains the poor outcome observed by Joseph et al (1991) . Accordingly, care should be taken during transplantation to allow the membrane to be a graft, thus promoting epithelial migration and proliferation. Zhou et al (2004) noted that severity of the symblepharon, severity of decrease in lacrimal function, and a decreased amount of remaining healthy conjunctiva are poor prognostic factors for long-term outcomes of amniotic membrane transplantation for conjunctival surface reconstruction. A higher rate of failure was associated with preoperative use of topical steroid in patients receiving amniotic membrane transplantation for persistent epithelial defect and conjunctival repair (Saw et al., 2007) . However, the preoperative use of steroids may simply be an indication of the severity of the disease. Traditionally, sutures are used to anchor the amniotic membrane to the ocular surface; however, there is a recent shift toward bioadhesive transfixation instead. There are a number of motivations for this shift: suture fixation requires a greater amount of surgical expertise and dexterity; sutures can cause corneal irritation and scarring; membrane shrinkage can result in graft loss; and sutures need to be extricated. For conjunctival autograft following pterygium excision, the biocompatibility, safety, and efficacy of fibrin bioadhesives was substantiated in a prospective randomized, interventional case series (Uy et al., 2005) . In a rabbit model, Szurman et al (2006) demonstrated that fibrin glue provided a better surgical outcome than sutures for amniotic membrane transplantation. In the bioadhesive group, histology revealed a smooth fibrin layer at the graft-host interface and a continuous, stratified layer of cytokeratin-3 expressing corneal epithelial cells on the membrane surface. The authors found that suture fixation tends to promote membrane contraction, raised membrane edges, and epithelial ingrowth into the submembrane space (Szurman et al., 2006) . These findings were essentially corroborated in another study (Sekiyama et al., 2007) . The fibrin bioadhesive biodegrades within 2 weeks, whereas the amniotic membrane persists for at least 12 weeks, providing sufficient time for epithelialization (Sekiyama et al., 2007) . Sutureless transplantation with fibrin glue or ProKera™ is reportedly a safe and easy method that avoids complications related to sutures and shortens the time of surgery (Kheirkhah et al., 2006) .
Disadvantages of human amniotic membrane
Amniotic membrane only provides a supportive substratum for epithelial stem cells to proliferate and migrate to restore the ocular surface. Thus, transplantation of the amniotic membrane without cultivated epithelial cells for true limbal stem cell deficiency may not be curative. Without the limbal stem cells and corneal epithelial cells, the cornea may not maintain avascularity and clarity because of secondary conjunctivalization and neovascularization of the cornea. In a retrospective case study, Maharajan et al (2007) reported the correlation between a higher success rate of ocular surface reconstruction using amniotic membrane transplantation and the availability of stem cells. There are some minor disadvantages of amniotic membrane transplantation. As already noted, suture fixation of amniotic membrane requires surgical dexterity to manipulate the membrane on the ocular surface. As a substrate for stem cell expansion, the surface with stem cells is transfixed face-up on the corneal surface. This position has some theoretical drawbacks: delayed migration of epithelial cells to the corneal surface before cellular repopulation, attrition of epithelial cells from exposure in patients with severe dry eye syndrome or ocular surface disorders, or mechanical displacement of the tissue. Another disadvantage is the association with corneal calcific opacification. In a large series of amniotic membrane transplantation for persistent epithelial defect, partial limbal stem cell deficiency and conjunctival reconstruction, Anderson and colleagues (2003) reported a significant (12.8%) rate of corneal calcification, occurring 3-17 weeks postoperatively. Risk factors were preoperative corneal calcification in either eye and postoperative use of phosphate-containing eye drops. A more recent study suggests that the use of phosphatebuffered eye drops, commonly found in artificial tear or topical corticosteroid formulations, favors the formation of insoluble crystalline calcium phosphate hydroxyapatite deposits in the stroma in the presence of epithelial keratopathy . Studies using an animal model confirmed these findings as well (Schrage et al., 2010) . The authors discouraged the use of phosphate-buffered eye drops as excessive use of such eye drops may cause corneal calcification, which may necessitate corneal graft surgery for subsequent visual rehabilitation.
Epithelial cell transplantation
Treatment of limbal stem cell deficiency includes transplantation of cultivated limbal stem cells. The unique properties of amniotic membrane make it an attractive candidate as a substratum for stem cell expansion. Tsubota and colleagues (1996) were among the first to introduce the combined transplantation of allograft limbal tissue and amniotic membrane in www.intechopen.com patients with ocular cicatricial pemphigoid, where a short-term success rate of 86% was observed. reported successful transplantation of cultivated corneal epithelium using acellular amniotic membrane as a substrate for ex vivo expansion of the epithelial cells. proposed the application of sterilized, freezedried amniotic membrane as a substrate for cultivating autologous corneal epithelial cells for ocular surface reconstruction. In a rabbit model, the authors reported no significant difference between freeze-dried and cryopreserved amniotic membrane. Corneal epithelium cultivated well and reepithelialization of the grafted cornea was demonstrated postoperatively (Nakamura et al., 2004, 2006) . The conventional cultivation methods for mucosal epithelial tissues involve the use of xenobiotic materials such as fetal bovine serum (FBS) and murine-derived 3T3 feeder cells. ). These findings were corroborated by another group (Han et al., 2002) . A more recent study comparing fibrin bioadhesive substrate and amniotic membrane for cultivation of corneal epithelial sheets showed that both had similar levels of colony-forming progenitor cells, while more differentiation was observed in the fibrin group (Higa et al., 2007) . A thermoresponsive surface, which allows easy harvest of intact transplantable corneal epithelial cell sheets from ex vivo expansion of limbal stem cells, has been developed . Without transplantation of the substratum, e.g. amniotic membrane, theoretically, this epithelial sheet will rapidly repopulate the corneal surface, without the time delay for migration. Using this technique, performed ex vivo fabrication of autologous oral mucosal tissue and transplantation on a small group of four patients with bilateral total corneal stem cell deficiencies with reasonable success. also demonstrated successful transplantation of bioengineered human corneal endothelial cell monolayer sheet grafts, cultivated on the thermoresponsive surface then attached to gelatin hydrogel discs, into denuded rabbit corneas. Restoration of corneal clarity was observed, compared to controls. An innovative approach to cultivating cells on contact lens has recently been introduced (Di Girolamo et al., 2007). It was found that successful explant cultures could be made using either superior forniceal conjunctiva or superior limbal epithelial biopsies placed on a siloxane-hydrogel extended wear contact lens. These lenses were subsequently inserted onto the eyes of three patients with limbal stem cell deficiency. The patients were found to have a stable transparent corneal epithelium with no recurrence of conjunctivalization or corneal vascularization along with improvements in both best-corrected visual acuity and symptom scores. It is theorized that the close proximity between the therapeutic contact lens and the ocular surface facilitates cell migration from their artificial substratum to replenish the damaged ocular surface. Di Girolamo et al also postulated that the diffusion of secretory factors from the contact lens niche would promote corneal wound healing, inhibit angiogenesis, and rescue or activate any remaining limbal stem cells. Research is now being conducted to create a plasma polymer surface that can coat CL surfaces that would not only allow for appropriate attachment and growth of the epithelial cells but also transfer of the cultured cells onto the denuded corneal surface once inserted (Deshpande et al., 2010) . This technology is similar to that being used in patients with extensive burn injuries and chronic nonhealing diabetic ulcers for transfer of autologous keratinocytes (Moustafa et 
Autologous non-ocular tissues
As discussed in the conjunctival section, when available, transplantation of autologous tissues is the treatment of choice to obviate the risks of allograft rejections despite the presence of the anterior chamber immunologic privilege. In cases of bilateral severe limbal stem cell deficiency, oral mucosal transplantation is an adequate alternative. Kinoshita and Nakamura proposed a two-step process for patients at increased risks for allograft rejection or patients having low tolerance for immunosuppressive therapies. Here, the autologous oral mucosal epithelial progenitor cells undergo ex vivo expansion prior to transplantation (Kinoshita & Nakamura, 2004) . Ex vivo expansion of a carrier-free sheet is more beneficial than a direct transplantation of an autologous buccal mucosal graft because the latter typically contain opaque subepithelial fibrous tissue. A long-term study reported good epithelial coverage, regression or stabilization of corneal neovascularization, and improved visual acuity in a cohort of patients with severe ocular surface disorder (Inatomi et al., 2006; Nakamura et al., 2010). The main mechanisms of graft failure were loss of transplanted cultivated oral epithelial cells, leading to persistent epithelial defect, followed by invasion of neighboring conjunctival epithelial cells, infiltration of inflammatory cells, and neovascularization. And as expected, good graft survival, intact ocular surface integrity, and no inflammatory cell infiltration were observed in successful cases, . Another study also showed good results using human buccal mucosa cultivated on thermoresponsive surface with mitomycin-treated 3T3 feeder cells for patients with chronic conjunctival inflammation and limbal stem cell depletion (Nishida et The advantages of these autologous tissues are a significant reduction of xenobiotic materials in the transplant, a decreased risk of infection, a minimized risk of allograft immunologic rejection, and a reduced need for immunosuppressive therapy. However, some authors still used the 3T3 murine feeder cells. Also, it would be intriguing to look at long-term restoration of corneal avascularity and clarity as these tissues are not corneal epithelium and do not possess innate limbal stem cells.
Corneal tissue substitutes
Severe ocular surface diseases not only affect the epithelium but also involve the corneal stroma as well. Thus, reconstitution of the ocular surface may provide symptomatic relief but not visual rehabilitation. Tissue bioengineering is required to regenerate corneal tissue equivalents that integrate into the host and restore vision. A number of substrates have been proposed as three-dimensional growth scaffolds for ocular tissues: irradiated acellular nonhuman cornea disc (Zhang et Since corneal stroma is composed of lamella of collagen fibrils, many investigators developed collagen-surface modified scaffolds to promote host tissue integration, repair and regeneration. Of note, colleagues (2007, 2008) used photolithography to construct a three dimensional collagen type I -poly(ethylene glycol)/poly(acrylic acid) "core and skirt" corneal prosthesis, which can support surface reepithelization and stromal www.intechopen.com integration. In a rabbit model, the authors observed that corneal epithelium forms a confluent layer on the scaffold. The surface modification of collagen also assisted in the integration of the seeded corneal fibroblasts into the hydrogel skirt. Li et al (2003) performed lamellar keratoplasty using collagen-copolymer extracellular matrix scaffold in pigs. The authors reported increased procollagen synthesis and nerve regeneration, compared to control. Similar findings were reported by Liu et al (2006) using corneal substitutes made of cross-linked porcine type I collagen and water-soluble carbodiimides, in rabbit and minipig models. Using recombinant human collagens cross-linked with carbodiimide and hydroxysuccinimide, Merrett et al (2008) constructed bioengineered corneal equivalents for transplantation into minipigs. These synthetic corneal implants were found to be optically clear, with good epithelial coverage. Importantly, the authors also demonstrated repopulation of the synthetic stroma with host corneal stromal cells, as well as reinnervation with similar nerve density compared to allograft.
Ocular surface prosthetic devices
As discussed above, contact lenses are being investigated as a stem cell reservoir and delivery vehicle. Therapeutic applications of contact lenses extend to other uses as well, for symptomatic alleviation of aberrant ocular surface and drug delivery. Many individuals suffer severe eye discomfort and pain that is unresponsive to the mainstay treatment options. In these patients, the ocular surface can be improved by an ocular surface prosthetic device -not for limbal stem cell delivery but to create a microenvironment that supports the corneal surface, i.e. the Prosthetic Replacement of the Ocular Surface Ecosystem or PROSE, developed by Perry Rosenthal. The device itself is a fluid-ventilated, gas-permeable polymer with optic and haptic portions situated over the sclera that are linked to a transitional zone that suspends the lens over the cornea without contact. The unique design of this prosthesis provides a constant aqueous layer over the cornea surface, which contributes to healing of the corneal tissue and subsequent relief of symptoms (Rosenthal et , 2002) . Accordingly, the use of contact lenses as drug delivery vehicles has been investigated. Sedlavek (1965) in Czechoslovakia first studied the use of soft contact lenses for drug delivery; since then many different drugs and technologies have been successfully tried using this technique (Sedlavek, 1965) . The optimal design for a contact lens drug delivery system is one that allows for zero-order release kinetics, along with being comfortable and biocompatible (Ciolino et al., 2009 ). With these criteria in mind, the soft hydrogel lenses were the first lenses to be used in this capacity. The hydrogel lenses have high water content and large intermolecular pores, which allow them to absorb water soluble drugs and release them with a large initial pulse and then gradually thereafter (Jain, 1988) . To maintain first-order kinetics, the hydrogel lens requires regular instillation of drops at intervals of 2-4 hours or reapplication of a soaked lens (Jain & Batra, 1970 ). This approach is suboptimal as drug www.intechopen.com uptake and release kinetics are dependent on the equilibrium solubility of the drug present in the lens matrix (which is small for most of the hydrophobic drugs [Gulsen et al., 2004] ), the inconvenience of frequent dosing, and the waste of drug remaining in the soaking solution. Efforts to overcome these limitations focus on lens designs that allow for a sustained release of therapeutic dosage. One idea involves the use of nanoparticles in which the ophthalmic drug could be encapsulated and then dispersed in the lens material (Gulsen et al., 2004) . These so called "drug-laden hydrogels" were found to release therapeutic levels of drugs for a few days with the ability to manipulate drug delivery rates by varying the load of nanoparticles in the gel (Gulsen et al., 2004) . This discovery allowed for lenses that could release drugs over extended periods of time and thus behaved in a zero order kinetic fashion. However, although this was exciting, the development of a sustained, long-term drug delivery system that functions under the physiological temperature, pH and salinity of the eye continues to be problematic (Ciolino et al., 2009 ). Most recently, research is being conducted on the development of prototype lenses that incorporate a dual polymer system such that there is a polymer film containing the drug compounds; the film is then coated with a transparent polymer that is used in contact lenses (Ciolino et al., 2009 ). The results with this new lens showed that there could be controlled release with zero-order kinetics for over 4 weeks (Ciolino et al., 2009 ). In addition to the soft hydrogel lens and their derivatives, collagen shields have also proven to be effective delivery modalities. The collagen shield contact lens is a therapeutic lens composed of non-cross linked porcine collagen with the capability of dissolving on the corneal surface over a period of around 12 hours (Phinney et al., 1988) . Studies done using collagen shields soaked with gentamicin and vancomycin produced tear, cornea, and aqueous humor levels that were generally higher or comparable to those achieved through frequent drop administrations (Phinney et al., 1988) . Further, collagen shields used for heparin delivery in postoperative rabbit eyes helped to prevent postoperative fibrin formation in eyes at risk for this complication (i.e. eyes requiring surgery for complications of proliferative diabetic retinopathy and glaucoma filtration surgery) (Murray et al., 1990 ). With time, as bioengineered materials continue to advance, so too will the quality of optimal delivery system contact lenses. Pharmacological contact lenses have the potential to revolutionize the current drug delivery modalities and conquer new ground in the long held battle of medication wastage and systemic absorption side effects.
Restoration of lacrimal function
Dry eye syndrome or dysfunctional tear syndrome is a chronic ailment, afflicting up to ten million people in the United States alone, and affecting women twice as often as men . As prevalent as it is, currently, there is only one medication (cyclosporine ophthalmic emulsion, 0.05%) approved by the Food and Drug Administration for decreased tear production due to ocular inflammation (Barber et al., 2005; Pflugfelder, 2004) . Dry eye syndrome tends to coexist with ocular surface disorder. Importantly, poor lacrimal function correlates with poor surgical outcomes in ocular surface reconstructions, especially stem cell transplantation (Nguyen et al., 2008; Shimazaki et al., 2000 Shimazaki et al., , 2007 . Temporary remedies, such as artificial tears, hydroxypropyl cellulose ophthalmic insert, punctal plugs, or moisture-chamber spectacles often provide only marginal relief and may interfere with the patient's quality of life. A long-term solution is the construction of an www.intechopen.com implantable lacrimal microbiosystem, which would house a colony of monolayer lacrimal acinar cells and produce tear fluid (Selvam et al., , 2008 .
Artificial lacrimal gland
The parenchyma of the lacrimal gland consists of specialized epithelia: ductal cells and acinar cells. The acinar cells form an acinus structure whose wall is composed of a polarized monolayer of cells. These lacrimal acinar epithelial cells are responsible for production and release of tear proteins such as lactoferrin, growth factors, secretory immunoglobulins, and lysosomal hydrolases into nascent tear fluid (Fullard, 1994) . Their apices point toward a central lumen into which tear fluid is secreted. Many acini form a lobule. The ductal cells line the intralobular and interlobular ducts, bringing tear fluid into the eye. An implantable lacrimal microbiosystem would approximate the structure and function of the lacrimal gland. Figure 2 depicts a schematic artificial lacrimal gland using a dead-end tube concept. Development of such devices faces many challenges. As with any implantable devices, a lacrimal microbiosystem must have a biologically compatible encapsulation to prevent rejection or toxicity to the host. However, the lacrimal microbiosystem encapsulation is much more intricate. Instead of a closed system, the enclosure must allow a dynamic bidirectional flux of ions, fluid, nutrients, and materials between the device and the host, while downregulating reactive fibroblastic proliferation in the surrounding environment that may diminish material transfer. Tear production is regulated by a variety of control modalities, such as regenerated intrinsic neurostimulation, extrinsic pharmacologic induction, or electronic excitation. Device construction includes ex-vivo seeding and maturation of the lacrimal acinar cells into a three-dimensional bioengineered scaffold. Strategic placement of pluripotent stem cells may be necessary. The stem cell clusters within www.intechopen.com the scaffold would repopulate the lacrimal acinar tissue, as needed. Precise stimuli for regeneration and terminal differentiation would be provided by extrinsic delivery or activation of previously implanted nanovesicles containing plasmids coding for growth factors, for example. As a stem cell device, safeguard mechanisms must be instituted to monitor and prevent autonomous unstructured proliferation and escape of the stem cells, i.e. tumorigenicity. Recent studies demonstrated monolayer growth of lacrimal acinar cells on Matrigel®, a biocompatible preparation rich in extracellular matrix molecules, i.e. laminin, collagen IV, heparin-sulfate proteoglycans, and growth factors (Selvam et al., , 2008 . Compared to other biocompatible polymeric materials, poly-L-lactic acid (PLLA)-Matrigel® substrate showed superior expression of monolayer acinar cell morphology. Active exocytosis vesicle profile was evident on electron microscopy, and maintenance of protein secretory functions was confirmed by -hexosaminidase catalytic activity assay. PLLA and PLGA copolymers have a wide range of applications: surgical sutures, scaffolds in bone augmentation and ligament restoration, osteoconductive materials in dental medicine, and components in vascular grafts, urethral stents, and nerve growth conduits. Growth of polarized lacrimal acinar cells on PLLA, which demonstrated the ability to maintain normal monolayer acinar cell morphology, secretory function, and EGF-dependent proliferation, suggests that PLLA may be a good candidate for the development of a tear secretory device. A dead-end tube construct using polyethersulfone has been reported (Li et al., 2006; ). After seeding the tube with cultured rat lacrimal acinar epithelial cells, the authors observed that a polyethersulfone dead-end tube may be suitable for attachment and proliferation of these cells, allowing its potential application as an artificial lacrimal gland.
Tear film measurements
Patients with ocular surface disorders typically have an underlying inflammatory process, such as ocular cicatricial pemphigoid, Stevens-Johnson syndrome, Sjögren syndrome, or post chemotherapy. The persistent inflammatory process and dysfunctional tear film lead to poor surgical outcomes. Good preoperative lacrimal function and a healthy conjunctival epithelium are important prognostic factors for limbal stem cell transplantation Shimazaki et al., 2000) . In fact, having a preoperative Schirmer's test > 10 mm correlates to a higher success rate for ocular surface reconstruction. Accordingly, preoperative characterization of tear film is important for ocular surface reconstruction. Traditionally, tear production and quality are accessed using vital dye stain, tear break-up time, Schirmer's test, or the cotton-thread test. However, these tests have suboptimal repeatability, inter-class correlation, and correlation between the test results and patient symptom 
Conclusion
The corneal epithelium, conjunctival epithelium, tear film and lacrimal system, and the eyelids constitute the functional ocular surface. Management strategies for severe ocular surface disorders involve treatment and prevention of recurrence of the causative condition, symptomatic alleviation, and reconstitution of the anatomic and physiologic ocular surface. Human amniotic membrane transplantation with or without epithelial graft is a versatile modality for various injuries to the ocular surface epithelia. Other options for reconstitution of the epithelia include suppression of cicatricial changes, autologous mucosal transplantation, or cultivated bioengineered tissues. Motivated by the risk of zoonotic disease transmission or xenobiotic immunogenicity, researchers worldwide are investigating serum-free feeder cell-free culture systems for ex vivo expansion of epithelial tissues for ocular surface applications. The results of these investigations are promising.
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Normal lacrimal function is not only important for symptomatic alleviation and optical pursuits; it is also exceedingly essential for surgical outcomes. Preoperative tear film is an important prognostic indicator for ocular surface reconstruction. Strategies for tear film restoration include lubrication, moisture chamber, and artificial lacrimal glands. www.intechopen.com
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